Activist Elliott makes inroads at Catalent to build value. Here’s what could happen next
Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical
Read MoreElliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical
Read MoreFounder Keith Meister was a protege of corporate raider Carl Icahn and was previously CEO of the billionaire's firm. Source
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreDeutsche Bank upgraded Catalent on Monday to buy from hold as the company's partnership with Moderna could help it grow
Read MoreWolfe Research warns investors to avoid these stocks with a low earnings quality score and a high potential to blow
Read MoreThe S&P 500 is headed toward its largest weekly losses since December. Take a look at this week's biggest gainers.
Read MoreGlobal stocks rose last week. These are the ones under the MSCI World index that posted gains of more than
Read MoreDozens of companies report earnings next week, but it may be big economic data, like Friday's jobs report, that takes
Read More